Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review-Reference-Cited by-同舟云学术

Impact of age and induction therapy on outcome of 180 adult patients with acute myeloid leukemia; retrospective analysis and literature review

Published:2020 Issue: Volume:14 Page:100206
ISSN:2213-0489
Container-title:Leukemia Research Reports
language:en
Short-container-title:Leukemia Research Reports

Author:

Abuelgasim Khadega A.,Albuhayri Bandar,Munshi Rayan,Mugairi Areej Al,Alahmari Bader,Gmati Giamal,Salama Hind,Alzahrani Mohsen,Alhejazi Ayman,Alaskar Ahmed,Damlaj Moussab

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference38 articles.

1. Howlader N N.A., Krapcho M., Miller D., Brest A., Yu M. et al. SEER cancer statistics review. National Cancer Institute Bethesda, MD 1975 -2016.

2. Therapeutic advances in acute myeloid leukemia;Burnett;J. Clin. Oncol.,2011

3. Acute myeloid leukemia;Dohner;N. Engl. J. Med.,2015

4. Grimwade D. Impact of cytogenetics on clinical outcome in AML. Acute myelogenous leukemia 2007:pp 177–92.

5. Development of minimal residual disease-directed therapy in acute myeloid leukemia;Freeman;Semin. Oncol.,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fluconazole and levofloxacin prophylaxis are ineffective strategies for preventing infections in acute myeloid leukemia patients undergoing chemotherapy;Cancer Epidemiology;2024-08

2. Treatment and clinical outcomes of patients with acute myeloid leukemia in Finland 2010–2020: A retrospective analysis of electronic health records;European Journal of Haematology;2024-07-29

3. Treatment challenges and outcomes of older patients with acute myeloid leukemia from India;Annals of Hematology;2024-07-08

4. Assessment of Complete Remission Rate in Patients with Acute Myeloid Leukemia Undergoing 7+3 Induction Chemotherapy;Pakistan Journal of Health Sciences;2024-06-30

5. Evaluating targeted therapies in older patients with TP53 -mutated AML;Leukemia & Lymphoma;2024-04-22